文献速递神经肿瘤

经眉弓眶上锁孔入路治疗鞍结节脑膜瘤:30例长期视觉预后与复发率系列研究

Trans-eyebrow supraorbital keyhole approach to tuberculum sellae meningiomas: a series of 30 cases with long-term visual outcomes and recurrence rates.
PubMed 文献 · J Neurooncol · 2019-02-22

该研究回顾性分析2006年12月至2018年8月经眉弓眶上锁孔入路(TSKA)治疗的30例鞍结节脑膜瘤(TSM)患者,平均随访58.0个月。27例(90.0%)实现全切除,1例(3.3%)术后9年复发;29例术前视力受损者中17例(58.6%)改善、8例(27.6%)稳定、4例(13.8%)恶化。结论认为TSKA创伤小、美容效果好,可作为治疗TSM的替代性微创入路。

要点

  • 30例TSM经TSKA治疗,全切除27例(90.0%),随访9年复发1例(3.3%)。
  • 29例术前视力受损者中17例(58.6%)改善,4例(13.8%)恶化。
  • 无围手术期死亡、脑脊液鼻漏或永久性内分泌功能障碍,所有患者美容效果满意。

核心结论

  • TSKA以创伤小和美容效果满意为特点,基于肿瘤特征和术者经验,可作为治疗TSM的替代性微创入路。

研究设计与样本

  • 回顾性分析2006年12月至2018年8月经TSKA治疗的30例TSM患者的医疗数据和随访结果。

主要发现

  • 共纳入5例男性和25例女性,其中3例为复发性TSM,平均肿瘤大小25.3±7.3 mm(范围10-48 mm)。
  • 平均随访58.0个月(四分位距33.5-86.3个月),27例(90.0%)实现全切除。
  • 1例(3.3%)在术后9年复发。
  • 29例术前视力受损者中,17例(58.6%)改善,8例(27.6%)稳定,4例(13.8%)恶化。
  • 无围手术期死亡、脑脊液鼻漏或永久性内分泌功能障碍,所有患者美容效果满意;末次随访时27例(90.0%)格拉斯哥结局量表评分为5分。

临床怎么用

  • 作者认为,基于肿瘤特征和术者经验,TSKA可作为治疗TSM的替代性微创入路。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Approach selection paradigm for tuberculum sellae meningiomas (TSMs) is still a point of discussion. The trans-eyebrow supraorbital keyhole approach (TSKA) is a minimally invasive transcranial approach and has been used for the treatment of TSMs during recent years. In this study, we presented a series of 30 cases of TSMs treated via TSKA with a long-term follow-up. METHOD: Thirty patients with TSMs underwent surgery via TSKA between December 2006 and August 2018. The medical data and follow-up results were retrospectively analyzed. RESULTS: A total of 5 males and 25 females were included in this study. Three patients presented with recurrent TSMs. The mean tumor size was 25.3 ± 7.3 mm (range, 10-48 mm). The mean follow-up period was 58.0 months (interquartile range, 33.5-86.3 months). Gross total resection (GTR) was achieved in 27 patients (90.0%). One recurrence (3.3%) occurred 9 years after surgery. Out of 29 patients with preoperative visual impairment, 17 (58.6%) improved, eight (27.6%) remained stable, and four (13.8%) deteriorated. No peri-operative death, CSF rhinorrhea, or permanent endocrine dysfunction occurred. All patients exhibited satisfactory cosmetic results. At the last follow-up, the glasgow outcome scale score was five in 27 patients (90.0%). CONCLUSION: The TSKA is characterized by minimal invasion with a satisfactory cosmetic outcome. Based on the tumor characteristics and surgeon's experience, this approach can be employed as an alternative minimally invasive approach for the treatment of TSMs.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Cai M, Hou B, Luo L, et al. Trans-eyebrow supraorbital keyhole approach to tuberculum sellae meningiomas: a series of 30 cases with long-term visual outcomes and recurrence rates. J Neurooncol. 2019. PMID: 30796744. doi:10.1007/s11060-019-03128-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。